EFX vs HBIO · P/E 54, rev $3.35B vs rev $22.7M
Equifax Inc (EFX) versus Harvard Bioscience Inc (HBIO) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. HBIO currently screens at market cap $20.3M.
Not investment advice. Open the EFX and HBIO stock pages for the full models.
Not investment advice.